Barbara Ryan serves as Executive at INVO Bioscience, Inc., where they oversee executive responsibilities. Since joining the company, Barbara Ryan has executed 17 insider transactions totaling $37.4K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 26, 2026 involved receiving (via award) 3,722 shares valued at $0.
Barbara Ryan currently holds 5,685 shares of INVO Bioscience, Inc. (INVO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Barbara Ryan has been a net buyer of INVO stock. They have purchased $37.4K and sold $0 worth of shares.
Barbara Ryan's most recent insider trade was on Jan 26, 2026, when they sold 3,722 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $35.39 |
| Discretionary |
| Dec 1, 2025 | INKT | $17.8K | Award | 1,601 | $11.09 | Discretionary |
| Sep 2, 2025 | INKT | $17.8K | Award | 1,281 | $13.86 | Discretionary |
| Sep 3, 2024 | INKT | $17.8K | Award | 21,649 | $0.82 | Discretionary |
| Jun 3, 2024 | INKT | $17.7K | Award | 17,841 | $0.99 | Discretionary |
| Mar 1, 2024 | INKT | $17.8K | Award | 18,685 | $0.95 | Discretionary |
| Dec 1, 2023 | INKT | $17.8K | Award | 17,068 | $1.04 | Discretionary |
| Sep 1, 2023 | INKT | $17.8K | Award | 12,158 | $1.46 | Discretionary |
| Jun 1, 2023 | INKT | $17.8K | Award | 10,086 | $1.76 | Discretionary |
| Mar 1, 2023 | INKT | $17.8K | Award | 8,493 | $2.09 | Discretionary |
| Dec 1, 2022 | INKT | $17.8K | Award | 6,801 | $2.61 | Discretionary |
| Sep 15, 2022 | INKT | $35.5K | Award | 13,550 | $2.62 | Discretionary |
| Jun 1, 2022 | INVO | $10.0K | Purchase | 10,526 | $0.95 | Discretionary |
| Jan 15, 2022 | INVO | $0 | Award | 8,588 | $N/A | Discretionary |
| Dec 31, 2020 | INVO | $0 | Award | 10,148 | $N/A | Discretionary |
| Nov 27, 2020 | INVO | $0 | Award | 2,317 | $N/A | Discretionary |